Rochester, NY 9/3/2009 9:10:16 PM
CTIC Cell Therapeutics, Inc. Morning Stock Trading 1.54 up 2.65% in 9:41am ET
CTIC Cell Therapeutics, Inc.
Last Trade: 1.54
Day's Range: 1.52 - 1.54
Trade Time: 9:41am ET
52wk Range: 0.05 - 2.50
Change: Up 0.04 (2.65%)
Volume: 2,693,621
Prev Close: 1.50
Avg Vol (3m): 25,185,800
Open: 1.53
Market Cap: 833.29M
StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
ABOUT Cell Therapeutics
Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin's lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington.
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll down this page or visit our site to join our free newsletter and begin receiving daily stock alerts.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
